• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

New Drugs

Novel drugs approved by regulators for human use.
A drug is positioned as new if it:
  • offers treatment for a disease for which no specific therapy previously existed
  • targets a new therapeutic target
  • has a new mechanism of action
  • is developed in a new formulation, optimized or improved
  • is part of a new combination drug
  • belongs to a new class of drug compounds.
Posted inNew Drugs, Oncology, Regulatory

Datroway/Datverzo: Groundbreaking New Way to Treat Lung Cancer

by Julia Mardi and Mark Gubar March 27, 2024March 27, 2024

Datopotamab deruxtecan for the treatment of unresectable NSCLC after failure of first-line therapy.

Posted inCardiology, New Drugs, Rare/Orphan Diseases, Regulatory

Winrevair: Game-Changer in Pulmonary Arterial Hypertension Treatment

by Nik Resovski March 22, 2024April 5, 2024

Sotatercept is the first drug that actually modifies PAH.

Posted inMetabolism, New Drugs, Rare/Orphan Diseases, Regulatory

Lenmeldy/Libmeldy: Most Expensive Drug in the World

by Mark Gubar March 21, 2024April 2, 2024

Atidarsagen autotemcel is a gene therapy for metachromatic leukodystrophy (MLD).

Posted inCardiology, Metabolism, New Drugs, Regulatory

Tryvio: Brand New High Blood Pressure Medication

by Tanya von Reuss March 20, 2024April 5, 2024

Aprocitentan for the treatment of resistant arterial hypertension.

givinostat
Posted inNeuroscience, New Drugs, Rare/Orphan Diseases, Regulatory

Duvyzat: Givinostat for Duchenne Muscular Dystrophy Treatment

by Mark Gubar March 20, 2024April 2, 2024

Oral givinostat delays the progression of DMD.

Posted inNew Drugs, Oncology, Regulatory

Tevimbra: Immuno-Oncologic Treatment for Esophageal Cancer

by Julia Mardi March 19, 2024April 2, 2024

Tislelizumab for the treatment of unresectable or metastatic esophageal squamous cell carcinoma.

insulin
Posted inAutoimmune Diseases, Metabolism, New Drugs, Regulatory

Awiqli: Basal Insulin Once a Week

by Tanya von Reuss and Mark Gubar March 14, 2024April 5, 2024

Novo Nordisk invented insulin icodec, a very patient-friendly ultra-long-acting insulin.

Posts pagination

Newer posts 1 2 3 4 … 13 Older posts
BioPharma News Logo
Biopharmaceutical industry analysis.
© 2025 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×